- Home
- Slides
- Home
- Tools and Resources
- Research Summaries for Consumers, Clinicians, and Policymakers
- Search for Research Summaries, Reviews, and Reports
- Research Available for Comment
- Submit a Suggestion for Research
- Submit Scientific Information Packets
- Comparative Effectiveness Research Grant and ARRA Awards
- News and Announcements
- What Is Comparative Effectiveness Research
- Who Is Involved in the Effective Health Care Program
- What Is the Effective Health Care Program
Slides
Slides: 1–12 of 88
Comparative Effectiveness of Recombinant Factor VIIa for Off-Label Uses vs. Usual Care in the Hospital Setting
Outline of Study
Introduction to Recombinant Activated Factor VII (rFVIIa)
The Coagulation Cascade: rFVIIa Mechanism of Action
Off-Label Uses of rFVIIa
The CER Development Process (1)
The CER Development Process (2)
Framework for Analyzing Outcomes of Off-Label rFVIIa Use in the Hospital Setting
Clinical Questions Addressed by the Comparative Effectiveness Review
Outcomes of Interest for Off-Label rFVIIa Use in the Hospital Setting
Four Domains Used To Assess Relevant Studies
Rating the Strength of Evidence From the CER
Your slide tray is being processed.